0.52 USD
▲+0.00+11.33%
盘后 0.45 -3.64%
2026-08-03
市值
$18.38M
市盈率
—
EPS
-0.44
股息率
—
52 周区间
0.39 – 1.98
成交量
151.53K
Beta
1.56
目标价
6.50
52W 低 0.3952W 高 1.98
价格走势
公司简介
NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on discovering and developing treatments for patients suffering from neurodegenerative diseases in the United States and internationally. The company’s lead product is PrimeC, an extended-release oral formulation of a fixed-dose combination of ciprofloxacin and celecoxib, currently under Phase 2b/3 clinical trials for the treatment of amyotrophic lateral sclerosis, and completed Phase 2 clinical trials for the treatment of Alzheimer’s, as well as under preclinical stu...